Saturday, June 13, 2026

Latest

‘More of an Instinct’: Trump Explains How He’ll Decide Which Companies Get Tariff Exemptions

President Donald Trump revealed Wednesday he may grant exemptions to certain companies hurt by his sweeping tariffs based primarily on his “instinct” rather than established economic analysis.

“You almost can’t take a pencil to paper. It’s really more of an instinct than anything else,” Trump told reporters during a press conference with Treasury Secretary Scott Bessent. “Some companies, through no fault of their own, they happen to be in an industry that is more affected by these things than others.”

The vague process, without established guidelines or oversight, creates a situation where companies may need to appeal directly to the administration for relief. Trump’s statement that “you have to be able to show a little flexibility, and I’m able to do that” suggests a personalized approach to exemptions that could advantage businesses with stronger connections to the White House.

The administration has already carved out exemptions for approximately $644 billion in imports following Trump’s “Liberation Day” tariff announcements, which imposed a 10% universal tariff on imported goods plus higher “reciprocal” tariffs targeting China and European Union countries. 

The Wall Street Journal reports $185 billion of these exemptions benefit goods from Canada and Mexico, though these nations face other trade restrictions.

Trump’s approach to trade policy has introduced significant uncertainty for businesses. His metaphorical explanation about needing to go “under the wall, around the wall or over the wall” when obstacles appear did little to clarify his decision-making process, instead highlighting the unpredictable nature of the exemption system.

Pharmaceutical companies, temporarily exempted while undergoing a Section 232 investigation, may soon face what Trump described as “a major tariff” despite the ongoing review. At a National Republican Congressional Committee dinner Tuesday night, Trump indicated pharmaceutical tariffs would be announced “very soon,” suggesting the investigation’s outcome may already be predetermined.

Related: Kimbal, Elon Musk’s Brother, Calls Out Trump For “Permanent Tax” On US Consumer


Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Canadian Dream Is Leaving Canada | Spencer Gatten

Allied Gold: The Zijin Deal Is On The Rocks

Why Silver’s Drop May Not Mean the Bull Market Is Over | Peter Krauth

Recommended

Silver47 Starts 10,000 Metre Campaign at Flagship Alaska Silver Project

Blue Jay Gold Launches 16,000 Metre Drill Program At Steller

Related News

Europe Strikes Back With Proposed 25% Tariffs On US Goods

The European Commission has unveiled a proposal to impose 25% counter-tariffs on a variety of...

Tuesday, April 8, 2025, 10:31:00 AM

Trump Tariffs Odds Plunge After Supreme Court Presses Executive Limits

The odds that the Supreme Court will uphold President Donald Trump’s tariffs collapsed to as...

Thursday, November 6, 2025, 12:54:00 PM

US Leverages Trade Talks to Push Starlink Expansion, Documents Show

The United States is leveraging tariff negotiations to secure foreign regulatory approvals for Elon Musk’s...

Thursday, May 8, 2025, 11:38:00 AM

Tariff Tantrum: Trump Targets Canada’s Digital Tax

President Donald Trump recently signed a memo aimed at retaliating against nations that tax American...

Tuesday, February 25, 2025, 02:10:00 PM

The Battle For Trump’s Heir: Vance Vs. Rubio

An X post alleged that President Donald Trump has been exploring ways to force Vice...

Wednesday, May 27, 2026, 04:01:00 AM